Le Lézard
Classified in: Health
Subjects: POL, TRD

Folium Biosciences Receives Approval from Public Health Inspections Division, Denver Department of Environmental Health, to Manufacture & Sell Hemp CBD Oil in the City of Denver


COLORADO SPRINGS, Colo., Sept. 19, 2017 /PRNewswire/ -- The new regulations, which recently took effect, require that the Department of Environmental Health inspects and approves all suppliers of hemp derived phytocannabinoid rich products that are sold within the City of Denver. Hemp derived products containing CBD that is imported from China and Europe is no longer allowed to be sold within the City of Denver. Folium Biosciences believes that the new regulations are an important first step to maintaining higher levels of quality control and oversight in one of the fastest growing verticals within the legal cannabis industry - hemp derived cannabidiol (CBD) based products.

The City of Denver in Colorado is the very first city in the United States to create oversight for hemp manufacturers of products sold within the city. The Department of Environmental Health approvals mean that all of Folium's bulk and wholesale customers may sell their retail branded hemp CBD oil products throughout the city of Denver.

About Folium: Folium Biosciences, based in Colorado Springs, CO is the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoid rich products in the USA. All of Folium Biosciences Hemp is registered with the Colorado State Department of Agriculture and grown in accordance with section 7606 of the 2014 US Farm Bill.

For Media:
Contact: [email protected]

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

 

SOURCE Folium Biosciences


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: